Riskpilot← Back to searchSign inGet full accessNURVEN AS
ASActiveOrg 997416139Storgaten 27B, 3126 TønsbergRental and operating of own or leased real estate · NACE 6820Est. 20110 employees
Revenue 2024
NOK 0
EBITDA margin
—
-22% vs 2023
Equity ratio
53.4%
Financial strength
Net profit 2024
NOK -184K
-97% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -118K | -22% |
| Net profit | NOK -184K | -97% |
| Total assets | NOK 23,3M | -2% |
| Equity | NOK 12,5M | -1% |
| Employees | 0 | — |
Legal name
NURVEN AS
Org number
997416139
Legal form
Aksjeselskap
NACE code
6820 · Rental and operating of own or leased real estate
Founded
1. oktober 2011
Share capital
NOK 400 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Investering i eiendommer, aksjer, verdipapirer og hva som dermed står i forbindelse, herunder også deltagelse i andre selskap.
Address
Storgaten 27B, 3126 Tønsberg
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −585 | −302 | −396 | −97 | −118 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −585 | −302 | −396 | −97 | −118 |
| Net financials | 927 | 3 001 | 396 | −23 | −62 |
| Profit before tax | 342 | 2 699 | 0 | −120 | −180 |
| Tax | 11 | 20 | −19 | −26 | 4 |
| Net profit | 331 | 2 679 | 19 | −93 | −184 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 25 970 | 23 527 | 24 832 | 23 859 | 23 324 |
| Equity | 12 475 | 12 913 | 12 732 | 12 639 | 12 454 |
| Long-term debt | 8 084 | 5 610 | 7 780 | 7 654 | 7 261 |
| Short-term debt | 5 411 | 5 004 | 4 320 | 3 567 | 3 609 |
| Total debt | 13 495 | 10 614 | 12 100 | 11 220 | 10 870 |
EBITDA margin
-11756800.0%
This company
15.8%
Market median
-74410227% vs market
20202024
Equity ratio
53.4%
This company
38.2%
Market median
+40% vs market
20202024
Return on equity
-1.5%
This company
18.4%
Market median
-108% vs market
20202024
Net profit margin
-18442700.0%
This company
8.1%
Market median
-227687754% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.87×
This company
0.62×
Market median
+40% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2015 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
NURVEN AS 
LAB 7 ASBoard members of NURVEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Pål-Espen Tannmand | Chairman | 0 companies |